FDA Approved: EXFORGE — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved EXFORGE, a fixed-dose combination of amlodipine besilate and valsartan, under an original NDA from Novartis, for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

ORIG AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)